Koers Avricore Health Inc Toronto S.E.
Aandelen
APH
CA92143R2046
Farmaceutische producten
Omzet 2021 | 123K 89,77K 84,02K | Omzet 2022 | 1,77 mln. 1,29 mln. 1,21 mln. | Marktkapitalisatie | 31,26 mln. 22,85 mln. 21,39 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -1 mln. -731K -684K | Nettowinst (verlies) 2022 | - 0 0 | EV/omzet 2021 | 111 x |
Nettoliquiditeiten 2021 | 1,97 mln. 1,44 mln. 1,35 mln. | Nettoliquiditeiten 2022 | 591K 432K 404K | EV/omzet 2022 | 17,3 x |
K/w-verhouding 2021 |
-8,67
x | K/w-verhouding 2022 |
-37,7
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 90,31% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hector Bremner
CEO | Chief Executive Officer | - | 01-01-19 |
Kiki Smith
DFI | Director of Finance/CFO | - | 06-08-19 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 08-12-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 20-01-16 |
Robert Sindelar
BRD | Director/Board Member | 71 | 27-03-18 |
Christine Hrudka
BRD | Director/Board Member | - | 21-06-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |